Nasdaq dbtx.

Quick Take. Decibel Therapeutics (NASDAQ:DBTX) has filed to raise $100 million in an IPO of its common stock, according to an amended S-1 registration …Nov 16, 2023 · Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Oct 2023 to Nov 2023 Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Nov 2022 to Nov 2023 Latest DBTX Messages About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software, and services enables clients ...Decibel Therapeutics ( NASDAQ: DBTX) said its clinical trial application (CTA) received approval from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) for starting a phase 1/2 ...Find the latest Earnings Report Date for Decibel Therapeutics, Inc. Common Stock (DBTX) at Nasdaq.com.

BOSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

The stock was up 19.45% to $8.66 in after-hours trading. Pfizer-BioNTech COVID-19 Vaccine 100% Effective In Adolescent Population. Pfizer Inc. (NYSE:PFE) and its German partner BioNTech SE (NASDAQ ...Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...Decibel Therapeutics, Inc. (Nasdaq - DBTX) Under the terms of the Merger Agreement, Decibel will be acquired by Regeneron Pharmaceuticals, Inc. (Nasdaq - REGN). Decibel shareholders will receive ...16-Nov-2023 ... (NASDAQ: REGN) and Decibel Therapeutics, Inc. (NASDAQ: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing ...

BOSTON, March 21, 2023 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the appointment of Matthew Kapusta to its Board of Directors.“We are pleased to welcome …

BOSTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Decibel Therapeutics ( NASDAQ: DBTX) is an early-stage gene therapy company focused on developing new medicines for hearing and balance disorders. The company’s biological hypothesis is centered ...Decibel Therapeutics Inc (NASDAQ:DBTX) reported positive top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020 to protect against hearing loss in cancer ...The European Commission (EC) granted orphan drug designation to Decibel Therapeutics' (NASDAQ:DBTX) gene therapy DB-OTO to treat profound, congenital hearing loss caused by mutations of the ...Decibel Therapeutics (Nasdaq:DBTX) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech DBTX Decibel Therapeutics …Stock Symbol NASDAQ:DBTX ; Company Type For Profit; Contact Email [email protected]; Phone Number (617) 370-8701; Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction …Nov 22, 2021 · BOSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Aug 11, 2023 · BOSTON, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ... BOSTON, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Feb 12, 2021 · Follow. BOSTON, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to ... BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported positive top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020, a ...

Oct 27, 2023 · The average twelve-month price prediction for Decibel Therapeutics is $8.45 with a high price target of $23.00 and a low price target of $2.00. Learn more on DBTX's analyst rating history. Do Wall Street analysts like Decibel Therapeutics more than its competitors? BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug …

A few examples include what has shares of Yellow (NASDAQ: YELL), Wheels Up Experience (NYSE: UP) and Decibel Therapeutics (NASDAQ: DBTX) stock in the news today. You can catch up on all of this ...Decibel Therapeutics, Inc. (DBTX) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 3.2200 +0.2000 (+6.62%) At close: 03:59PM EDT. 1d. 5d. 1m.BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...NASDAQ, #2023-527, (UPDATED: Merger closed) Information Regarding the Tender Offer of Decibel Therapeutics, Inc. (DBTX). Sep 18, 2023, NASDAQ, #2023-526, ( ...BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...

Decibel Therapeutics ( NASDAQ: DBTX) said its clinical trial application (CTA) received approval from the U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) for starting a phase 1/2 ...

1,992.00 -0.80(-0.04%) Decibel Therapeutics, Inc. (DBTX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.9100 0.0000 (0.00%) At close: 03:00PM EST 1d 5d 1m 6m YTD 1y 5y...

TARRYTOWN, N.Y. and BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. (NASDAQ: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced a definitive agreement ...BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...BOSTON, May 10, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore ...Top Five Stock Market Gainers: TNGX, DBTX, MRTX, CTG, OPRTThe put contract at the $72.00 strike price has a current bid of $2.21. If an investor was to sell-to-open that put contract, they are committing to purchase the stock …Nov 16, 2023 · Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Oct 2023 to Nov 2023 Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Nov 2022 to Nov 2023 Latest DBTX Messages As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Decibel Therapeutics, Inc. (Nasdaq - DBTX) Under the terms of the Merger Agreement, Decibel will be acquired by Regeneron Pharmaceuticals, Inc. (Nasdaq - REGN). Decibel shareholders will receive ...

Nasdaq Stock Market LLC. 2023/10/12, 25-NSE, CPST, Capstone Green Energy Corp ... Sunlight Financial Holdings Inc. 2023/10/10, 15-12G, DBTX, Decibel Therapeutics ...Decibel Therapeutics, Inc. Common Stock (DBTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ...Instagram:https://instagram. paper trade options apppffafunded brokerstops stocks BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and... August 18, 2021 07:30 ET | Source: Decibel ...The deal also has an additional contingent payment of $3.50 per share for DBTX stock if certain milestones are met. At the $4 price for DBTX stock, this offer represents a 43.3% premium over its ... anguard federal money market fundstock projections Dec 3, 2023 · Decibel Therapeutics (NASDAQ:DBTX) has a recorded net income of -$63.01 million. DBTX has generated -$2.53 earnings per share over the last four quarters. What is Decibel Therapeutics's EPS forecast for next year? When the Nasdaq is said to be "down," that usually means that the Nasdaq Composite Index, an investment index comprised of some of the largest companies on the Nasdaq stock exchange, is losing value. This can be an indication that the broad... how to read candles Nov 16, 2023 · Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Oct 2023 to Nov 2023 Decibel Therapeutics (NASDAQ:DBTX) Historical Stock Chart From Nov 2022 to Nov 2023 Latest DBTX Messages Aug 28, 2023 · Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash ... Shareholders will receive $4.0000 and 1 share of DBTX^ for each share of DBTX previously held. ... NASDAQ. Copy link to clipboard. June 1, 2021. June 1, 2021.